Alternative splicing of pre-mRNAs is tightly regulated and any imbalance can change the outcome of gene expression which often leads to disease. Despite the importance of alternative splicing regulation our knowledge at the molecu...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BFU2014-54660-R
ACOPLAMIENTO FUNCIONAL ENTRE LA TRANSCRIPCION Y EL SPLICING
169K€
Cerrado
BFU2014-55058-P
MECANISMOS DE REGULACION DEL PROCESAMIENTO ALTERNATIVO DE PR...
593K€
Cerrado
AS-ARK-JV-GD
Regulation of coupling between transcription and splicing du...
191K€
Cerrado
EJC_SPLIC_HET
Role of the exon junction complex in the splicing of heteroc...
100K€
Cerrado
NCRNAS-SPLICING-FSHD
Aberrant gene expression and muscular dystrophy role of non...
1M€
Cerrado
Información proyecto ASCE
Líder del proyecto
Masarykova univerzita
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
100K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Alternative splicing of pre-mRNAs is tightly regulated and any imbalance can change the outcome of gene expression which often leads to disease. Despite the importance of alternative splicing regulation our knowledge at the molecular level is still in its infancy hampering development of effective therapies. We plan to study the regulatory RNA-protein and protein-protein interaction networks leading to skipping of CFTR exon 9 associated with severe forms of cystic fibrosis. Structure determination of regulatory complexes by NMR spectroscopy in combination with biochemical and functional in vivo studies will be used to deepen our molecular understanding of the regulatory networks governing the proper assembly of mRNAs. With this, we want to reveal the molecular basis of aberrant CFTR exon 9 splicing and lay a rational, structure-function-based foundation for novel approaches to cure diseases.